Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials
De Luca et al.
Eur Heart J 2009;30:2705-2713.
ABSTRACT
| FULL TEXT
Primary Percutaneous Coronary Angioplasty With and Without Eptifibatide in ST-Segment Elevation Myocardial Infarction: A Safety and Efficacy Study of Integrilin-Facilitated Versus Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction (ASSIST)
Le May et al.
Circ Cardiovasc Interv 2009;2:330-338.
ABSTRACT
| FULL TEXT
Effect of High-Dose Intracoronary Adenosine Administration During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: A Randomized Controlled Trial
Fokkema et al.
Circ Cardiovasc Interv 2009;2:323-329.
ABSTRACT
| FULL TEXT
Letter by Ryding et al Regarding Article, "Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Systematic Review"
Ryding et al.
Circulation 2009;120:e26-e26.
FULL TEXT
Influence of different antiplatelet treatment regimens for primary percutaneous coronary intervention on all-cause mortality
Witkowski et al.
Eur Heart J 2009;30:1736-1743.
ABSTRACT
| FULL TEXT
Options and outcomes with different antiplatelet strategies during primary percutaneous coronary intervention
Rajan and Moliterno
Eur Heart J 2009;30:1687-1689.
FULL TEXT
Antiplatelet Polypharmacy in Primary Percutaneous Coronary Intervention: Trying to Understand When More Is Better
Abdel-Latif and Moliterno
Circulation 2009;119:3168-3170.
FULL TEXT
Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction
Cantor et al.
NEJM 2009;360:2705-2718.
ABSTRACT
| FULL TEXT
A Comparison of Abciximab and Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Primary Percutaneous Coronary Intervention: A Meta-Analysis of Contemporary Randomized Controlled Trials
Gurm et al.
Circ Cardiovasc Interv 2009;2:230-236.
ABSTRACT
| FULL TEXT
New paradigms of care for STEMI focusing on mortality and attributable death analysis: what do device and drug trials teach us?
Mehran and Stone
Eur Heart J Suppl 2009;11:C4-C8.
ABSTRACT
| FULL TEXT
Emerging data and decision for optimizing STEMI management: the European perspective
Guagliumi
Eur Heart J Suppl 2009;11:C19-C24.
ABSTRACT
| FULL TEXT
Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis.
De Luca et al.
J Am Coll Cardiol 2009;53:1668-1673.
ABSTRACT
| FULL TEXT
The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect?
Brener
J Am Coll Cardiol 2009;53:1674-1676.
FULL TEXT
Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction
Fokkema et al.
Eur Heart J 2009;30:908-915.
ABSTRACT
| FULL TEXT
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network
Ortolani et al.
Eur Heart J 2009;30:33-43.
ABSTRACT
| FULL TEXT
Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials
De Luca et al.
Eur Heart J 2008;29:3002-3010.
ABSTRACT
| FULL TEXT
Randomized comparison between tirofiban and abciximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abciximab (FATA) in ST-elevation myocardial infarction trial
Marzocchi et al.
Eur Heart J 2008;29:2972-2980.
ABSTRACT
| FULL TEXT
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:
Authors/Task Force Members et al.
Eur Heart J 2008;29:2909-2945.
FULL TEXT
Adjunctive antithrombotic therapy during primary percutaneous coronary intervention
De Luca
Eur Heart J Suppl 2008;10:J2-J14.
ABSTRACT
| FULL TEXT
The GPIIb/IIIa (integrin {alpha}IIb{beta}3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend
Coller and Shattil
Blood 2008;112:3011-3025.
ABSTRACT
| FULL TEXT
Angioplasty Strategies in ST-Segment-Elevation Myocardial Infarction: Part I: Primary Percutaneous Coronary Intervention
Stone
Circulation 2008;118:538-551.
FULL TEXT
Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The Randomized Leipzig Immediate Percutaneous Coronary Intervention Abciximab IV Versus IC in ST-Elevation Myocardial Infarction Trial
Thiele et al.
Circulation 2008;118:49-57.
ABSTRACT
| FULL TEXT
Acute ST-Segment Elevation Myocardial Infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Goodman et al.
Chest 2008;133:708S-775S.
ABSTRACT
| FULL TEXT
Bivalirudin during Primary PCI in Acute Myocardial Infarction
Stone et al.
NEJM 2008;358:2218-2230.
ABSTRACT
| FULL TEXT
Antithrombotic Therapy to Support Primary PCI
Morrow
NEJM 2008;358:2280-2282.
FULL TEXT
The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up
Busk et al.
Eur Heart J 2008;29:1259-1266.
ABSTRACT
| FULL TEXT
Comparison of Angioplasty With Infusion of Tirofiban or Abciximab and With Implantation of Sirolimus-Eluting or Uncoated Stents for Acute Myocardial Infarction: The MULTISTRATEGY Randomized Trial
Valgimigli et al.
JAMA 2008;299:1788-1799.
ABSTRACT
| FULL TEXT
Should We Routinely Use Drug-Eluting Stents for Acute Myocardial Infarction?: Let's Wait and See
Grines et al.
J Am Coll Cardiol Intv 2008;1:136-138.
FULL TEXT
The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention insights from a large regional registry of contemporary percutaneous coronary intervention.
Gurm et al.
J Am Coll Cardiol 2008;51:529-535.
ABSTRACT
| FULL TEXT
The safety and efficacy of glycoprotein IIb/IIIa inhibitors for primary angioplasty: more options to choose and more time to decide.
Moliterno and Ziada
J Am Coll Cardiol 2008;51:536-537.
FULL TEXT
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment
Oldgren et al.
Eur Heart J 2008;29:315-323.
ABSTRACT
| FULL TEXT
Primary Percutaneous Coronary Intervention
Kapoor et al.
NEJM 2008;358:431-433.
FULL TEXT
Myocardial Revascularization with Percutaneous Devices
Wilson and Willerson
Card Surg Adult 2008;3:573-598.
FULL TEXT
Ventricular septal rupture following abciximab infusion
Arnold et al.
Eur J Echocardiogr 2008;9:60-62.
ABSTRACT
| FULL TEXT
Antiplatelet therapy in acute coronary syndromes
Gitt and Betriu
Eur Heart J Suppl 2008;10:A4-A12.
ABSTRACT
| FULL TEXT
Field triage to primary angioplasty combined with emergency department bypass reduces treatment delays and is associated with improved outcome
Carstensen et al.
Eur Heart J 2007;28:2313-2319.
ABSTRACT
| FULL TEXT
Reperfusion Strategies in Acute ST-Segment Elevation Myocardial Infarction: A Comprehensive Review of Contemporary Management Options
Boden et al.
J Am Coll Cardiol 2007;50:917-929.
ABSTRACT
| FULL TEXT
Clinical Aspects of Platelet Inhibitors and Thrombus Formation
Meadows and Bhatt
Circ. Res. 2007;100:1261-1275.
ABSTRACT
| FULL TEXT
Randomized Early Versus Late Abciximab in Acute Myocardial Infarction Treated With Primary Coronary Intervention (RELAx-AMI Trial)
Maioli et al.
J Am Coll Cardiol 2007;49:1517-1524.
ABSTRACT
| FULL TEXT
A comprehensive view of sex-specific issues related to cardiovascular disease
Pilote et al.
CMAJ 2007;176:S1-S44.
ABSTRACT
| FULL TEXT
Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up
Montalescot et al.
Eur Heart J 2007;28:443-449.
ABSTRACT
| FULL TEXT
Eptifibatide vs Abciximab as Adjunctive Therapy During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
Raveendran et al.
Mayo Clin Proc. 2007;82:196-202.
ABSTRACT
| FULL TEXT
Cancer Care, Money, and the Value of Life: Whose Justice? Which Rationality?
Sulmasy
JCO 2007;25:217-222.
ABSTRACT
| FULL TEXT
Glycoprotein IIb/IIIa Inhibitors in the Elderly: Fear of Age or Age of Fear?
Montalescot
Circulation 2006;114:2004-2006.
FULL TEXT
The pathology of myocardial infarction in the pre- and post-interventional era
Pasotti et al.
Heart 2006;92:1552-1556.
FULL TEXT
Thrombus Aspiration Before Primary Angioplasty Improves Myocardial Reperfusion in Acute Myocardial Infarction: The DEAR-MI (Dethrombosis to Enhance Acute Reperfusion in Myocardial Infarction) Study
Silva-Orrego et al.
J Am Coll Cardiol 2006;48:1552-1559.
ABSTRACT
| FULL TEXT
Narrative review: reperfusion strategies for ST-segment elevation myocardial infarction.
Ting et al.
ANN INTERN MED 2006;145:610-617.
ABSTRACT
| FULL TEXT
Percutaneous Coronary Intervention After Fibrinolysis: A Multiple Meta-Analyses Approach According to the Type of Strategy
Collet et al.
J Am Coll Cardiol 2006;48:1326-1335.
ABSTRACT
| FULL TEXT
Beneficial effects of abciximab in patients with primary percutaneous intervention for acute ST segment elevation myocardial infarction in clinical practice
Heer et al.
Heart 2006;92:1484-1489.
ABSTRACT
| FULL TEXT
Aspiration thrombectomy and primary percutaneous coronary intervention
De Luca et al.
Heart 2006;92:867-869.
ABSTRACT
| FULL TEXT
Three-year duration of benefit from abciximab in patient receiving stents for acute myocardial infarction in the randomized double-blind ADMIRAL study: reply
Montalescot
Eur Heart J 2006;27:1509-1509.
FULL TEXT
The Year in Interventional Cardiology
Dixon et al.
J Am Coll Cardiol 2006;47:1689-1706.
FULL TEXT
Impact of Routine Stenting on Clinical Outcome in Diabetic Patients Undergoing Primary Angioplasty for ST-Segment Elevation Myocardial Infarction
De Luca et al.
Diabetes Care 2006;29:920-923.
FULL TEXT
The role of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention for ST elevation myocardial infarction
Svilaas et al.
Eur Heart J 2005;26:2479-2481.
FULL TEXT
Part 5: Acute Coronary Syndromes
Circulation 2005;112:III-55-III-72.
FULL TEXT
Abciximab in the Treatment of ST-Segment Elevation Myocardial Infarction
Tan et al.
JAMA 2005;294:1760-1761.
FULL TEXT
The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes
Collet and Montalescot
Diabetes and Vascular Disease Research 2005;2:136-143.
ABSTRACT
Efficacy of primary PCI: the microvessel perspective
Ferenc and Neumann
Eur Heart J Suppl 2005;7:I4-I9.
ABSTRACT
| FULL TEXT
The use of GP IIb/IIIa inhibitors into new perspectives: pre-catheterization laboratory administration
Beygui and Montalescot
Eur Heart J Suppl 2005;7:I10-I14.
ABSTRACT
| FULL TEXT
The role of thrombectomy and embolic protection devices
Dudek et al.
Eur Heart J Suppl 2005;7:I15-I20.
ABSTRACT
| FULL TEXT
Patient selection bias in primary percutaneous coronary intervention trials: a critical issue
Migliorini and Antoniucci
Eur Heart J Suppl 2005;7:I21-I26.
ABSTRACT
| FULL TEXT
Clopidogrel for Percutaneous Coronary Revascularization: Time for More Pretreatment, Retreatment, or Both?
Moliterno and Steinhubl
JAMA 2005;294:1271-1273.
FULL TEXT
Reperfusion in acute myocardial infarction
DTB 2005;43:49-53.
ABSTRACT
| FULL TEXT
The Benefits of Abciximab in STEMI Patients
Journal Watch Cardiology 2005;2005:3-3.
FULL TEXT
What's new in the other general journals
Tonks
BMJ 2005;330:927-928.
FULL TEXT